tradmap

PAHC Financials Phibro Animal Health Corp

14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 10.1% per year over the past 5 years.
  • Net income has grown slower than revenue (7.5% vs 10.1% per year).
  • Operating margin has been roughly flat, at 8.5% in the latest year.
  • Free cash flow has grown 10.6% per year over the past 5 years.

Financial health

  • Total debt ($632M) exceeds cash ($68M); net debt is $564M.
  • Total debt has grown faster than revenue (29.9% vs 10.1% per year).
  • Operating income covered interest expense 3.0× in the latest year.
  • Total debt is 4.0× EBITDA.

Shareholder returns

  • Dividends have been paid for 6 consecutive years, consuming 40.3% of earnings and 46.5% of free cash flow.
  • The dividend has grown 0.0% per year over the past 5 years.
Revenue & net income
-$3M $647M $1B $0 2012 2014 2016 2018 2020 2022 2024
RevenueNet income
Margins (gross / operating / net)
0% 16% 33% 2012 2014 2016 2018 2020 2022 2024
GrossOperatingNet
Free cash flow (CFO − capex)
-$38M $20M $78M $0 2012 2014 2016 2018 2020 2022 2024
Free cash flow
Cash vs total debt
$0 $316M $632M 2012 2014 2016 2018 2020 2022 2024
CashTotal debt
Cash flow: operating / investing / financing
-$289M -$41M $207M $0 2012 2014 2016 2018 2020 2022 2024
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $1.3B $48M 30.9% 8.5% $42M $632M $68M
2024 $1.0B $2M 30.8% 5.2% $46M $312M $71M
2023 $978M $33M 30.5% 7.3% -$38M $334M $41M
2022 $942M $49M 30.3% 8.4% -$5M $288M $74M
2021 $833M $54M 32.6% 9.0% $19M — $50M
2020 $800M $34M 32.1% 8.6% $25M — $36M
2019 — $55M — — $17M — $58M
2018 — $65M — — $51M — $29M
2017 — $65M — — $78M — $56M
2016 — $83M — — $866000 — $34M
2015 — $60M — — — — $29M
2014 — -$3M — — — $286M $12M
2013 — $25M — — — $298M $27M
2012 — $7M — — — — $54M

Valuation over time

How the market has priced PAHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 205.0 409.9 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.9 1.7 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 2.5 5.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is PAHC growing its revenue and profit?

Over the past 5 years, Phibro Animal Health Corp's revenue has grown 10.1% per year, and net income grown 7.5% per year. These are computed facts, not advice.

How much debt does PAHC have?

As of FY2025, Phibro Animal Health Corp reported $632M of total debt against $68M of cash; operating income covered interest expense 3.0×.

What is PAHC's profit margin?

In FY2025, gross margin was 30.9%, operating margin 8.5%, and net margin 3.7%.

What is PAHC's P/E ratio?

As of Jun '26, Phibro Animal Health Corp traded at a price-to-earnings ratio of about 26.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.